Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

被引:0
|
作者
Shuai Xia
Jasper Fuk-Woo Chan
Lijue Wang
Fanke Jiao
Kenn Ka-Heng Chik
Hin Chu
Qiaoshuai Lan
Wei Xu
Qian Wang
Chao Wang
Kwok-Yung Yuen
Lu Lu
Shibo Jiang
机构
[1] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity
[2] The University of Hong Kong,State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine
[3] The University of Hong Kong-Shenzhen Hospital,Department of Clinical Microbiology and Infection Control
[4] Hong Kong Science and Technology Park,Centre for Virology, Vaccinology and Therapeutics
[5] Beijing Institute of Pharmacology and Toxicology,State Key Laboratory of Toxicology and Medical Countermeasures
来源
Cell Research | 2022年 / 32卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:404 / 406
页数:2
相关论文
共 50 条
  • [21] Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
    Qiao Wang
    Lujia Sun
    Shibo Jiang
    Signal Transduction and Targeted Therapy, 8
  • [22] Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
    Wang, Qiao
    Sun, Lujia
    Jiang, Shibo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [23] Active Ingredients of Reduning Injection Maintain High Potency against SARS-CoV-2 Variants
    XIAO Zhen
    XU Huan
    QU Zeyang
    MA Xinyuan
    HUANG Boxuan
    SUN Mengsi
    WANG Buqing
    WANG Guanyu
    Chinese Journal of Integrative Medicine, 2023, 29 (03) : 205 - 212
  • [24] Active Ingredients of Reduning Injection Maintain High Potency against SARS-CoV-2 Variants
    Zhen Xiao
    Huan Xu
    Ze-yang Qu
    Xin-yuan Ma
    Bo-xuan Huang
    Meng-si Sun
    Bu-qing Wang
    Guan-yu Wang
    Chinese Journal of Integrative Medicine, 2023, 29 : 205 - 212
  • [25] Active Ingredients of Reduning Injections Maintain High Potency against SARS-CoV-2 Variants
    Xiao Zhen
    Xu Huan
    Qu Ze-yang
    Ma Xin-yuan
    Huang Bo-xuan
    Sun Meng-si
    Wang Bu-qing
    Wang Guan-yu
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2023, 29 (03) : 205 - 212
  • [26] Active Ingredients of Reduning Injection Maintain High Potency against SARS-CoV-2 Variants
    XIAO Zhen
    XU Huan
    QU Ze-yang
    MA Xin-yuan
    HUANG Bo-xuan
    SUN Meng-si
    WANG Bu-qing
    WANG Guan-yu
    Chinese Journal of Integrative Medicine , 2023, (03) : 205 - 212
  • [27] Omicron variant in the current SARS-CoV-2 pandemic
    Nasiri, Kaveh
    Dimitrova, Aleksandra
    JOURNAL OF DENTAL SCIENCES, 2022, 17 (02) : 1041 - 1042
  • [28] Is Omicron the last SARS-CoV-2 Variant of Concern?
    Rahimi, Farid
    Abadi, Amin Talebi Bezmin
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (03) : 336 - 338
  • [29] Omicron: A highly transmissible SARS-CoV-2 variant
    Rahimi, Farid
    Abadi, Amin Talebi Bezmin
    GENE REPORTS, 2022, 27
  • [30] Is the Omicron variant of SARS-CoV-2 coming to an end?
    Zhao, Yingjie
    Huang, Jianping
    Zhang, Li
    Lian, Xinbo
    Wang, Danfeng
    INNOVATION, 2022, 3 (03):